{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:35:23Z","timestamp":1790948123956,"version":"4.1.0"},"reference-count":34,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"Suppl1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>\n                      Stereotactic radiosurgery (SRS) is characterized by high levels of conformity and steep dose gradients from the periphery of the target to surrounding tissue. Clinical studies have backed up the importance of these factors through evidence of symptomatic complications. Available data suggest that there are threshold doses above which the risk of symptomatic radionecrosis increases with the volume irradiated. Therefore, radiosurgical treatment plans should be optimized by minimizing dose to the surrounding tissue while maximizing dose to the target volume. Several metrics have been proposed to quantify radiosurgical plan quality, but all present certain weaknesses. To overcome limitations of the currently used metrics, a novel metric is proposed, the efficiency index (\u03b7\n                      <jats:sub>50%<\/jats:sub>\n                      ), which is based on the principle of calculating integral doses: \u03b7\n                      <jats:sub>50%<\/jats:sub>\n                      = integral dose\n                      <jats:sub>TV<\/jats:sub>\n                      \/integral dose\n                      <jats:sub>PIV50%<\/jats:sub>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>\n                      The value of \u03b7\n                      <jats:sub>50%<\/jats:sub>\n                      can be easily calculated by dividing the integral dose (mean dose \u00d7 volume) to the target volume (TV) by the integral dose to the volume of 50% of the prescription isodose (PIV50%). Alternatively, differential dose-volume histograms (DVHs) of the TV and PIV50% can be used. The resulting \u03b7\n                      <jats:sub>50%<\/jats:sub>\n                      value is effectively the proportion of energy within the PIV50% that falls into the target. This value has theoretical limits of 0 and 1, with 1 being perfect. The index combines conformity, gradient, and mean dose to the target into a single value. The value of \u03b7\n                      <jats:sub>50%<\/jats:sub>\n                      was retrospectively calculated for 100 clinical SRS plans.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      The value of \u03b7\n                      <jats:sub>50%<\/jats:sub>\n                      for the 100 clinical SRS plans ranged from 37.7% to 58.0% with a mean value of 49.0%. This study also showed that the same principles used for the calculation of \u03b7\n                      <jats:sub>50%<\/jats:sub>\n                      can be adapted to produce an index suitable for multiple-target plans (G\u03b7\n                      <jats:sub>12Gy<\/jats:sub>\n                      ). Furthermore, the authors present another adaptation of the index that may play a role in plan optimization by calculating and minimizing the proportion of energy delivered to surrounding organs at risk (OAR\u03b7\n                      <jats:sub>50%<\/jats:sub>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>The proposed efficiency index is a novel approach in quantifying plan quality by combining conformity, gradient, and mean dose into a single value. It quantifies the ratio of the dose \u201cdoing good\u201d versus the dose \u201cdoing harm,\u201d and its adaptations can be used for multiple-target plan optimization and OAR sparing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2018.7.gks18694","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T12:47:29Z","timestamp":1551185249000},"page":"118-124","source":"Crossref","is-referenced-by-count":33,"title":["A novel index for assessing treatment plan quality in stereotactic radiosurgery"],"prefix":"10.3171","volume":"129","author":[{"given":"Alexis","family":"Dimitriadis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Paddick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Adv Radiat Oncol","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.adro.2017.11.003","article-title":"Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS)","volume":"3","author":"Abraham C","year":"2017","unstructured":"Abraham C, Garsa A, Badiyan SN, Drzymala R, Yang D, DeWees T, : Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS). Adv Radiat Oncol 3:146\u2013153, 20172990473910.1016\/j.adro.2017.11.003"},{"key":"b2","series-title":"J Appl Clin Med Phys","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1120\/jacmp.v9i3.2803","article-title":"Unified dosimetry index (UDI): a figure of merit for ranking treatment plans","volume":"9","author":"Akpati H","year":"2008","unstructured":"Akpati H, Kim C, Kim B, Park T, Meek A: Unified dosimetry index (UDI): a figure of merit for ranking treatment plans. J Appl Clin Med Phys 9:2803, 20081871659610.1120\/jacmp.v9i3.2803"},{"key":"b3","series-title":"Cureus","doi-asserted-by":"publisher","first-page":"e587","DOI":"10.1016\/j.ijrobp.2009.07.1753","article-title":"Dose-volume response relationship for brain metastases treated with frameless single-fraction linear accelerator-based stereotactic radiosurgery","volume":"8","author":"Amsbaugh M","year":"2016","unstructured":"Amsbaugh M, Pan J, Yusuf MB, Dragun A, Dunlap N, Guan T, : Dose-volume response relationship for brain metastases treated with frameless single-fraction linear accelerator-based stereotactic radiosurgery. Cureus 8:e587, 20162728449510.1016\/j.ijrobp.2009.07.1753"},{"key":"b4","series-title":"Technol Cancer Res Treat","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/1533034616685025","article-title":"A dose-volume response model for brain metastases treated with frameless single-fraction robotic radiosurgery: seeking to better predict response to treatment","volume":"16","author":"Amsbaugh MJ","year":"2017","unstructured":"Amsbaugh MJ, Yusuf MB, Gaskins J, Dragun AE, Dunlap N, Guan T, : A dose-volume response model for brain metastases treated with frameless single-fraction robotic radiosurgery: seeking to better predict response to treatment. Technol Cancer Res Treat 16:344\u2013351, 201710.1177\/153303461668502528027696"},{"key":"b5","series-title":"BMC Cancer","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12885-018-4191-2","article-title":"The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases","volume":"18","author":"Andratschke N","year":"2018","unstructured":"Andratschke N, Alheid H, Allg\u00e4uer M, Becker G, Blanck O, Boda-Heggemann J, : The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. BMC Cancer 18:283, 20182953468710.1186\/s12885-018-4191-2"},{"key":"b6","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ijrobp.2009.06.006","article-title":"Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery","volume":"77","author":"Blonigen BJ","year":"2010","unstructured":"Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC: Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77:996\u20131001, 201010.1016\/j.ijrobp.2009.06.00619783374"},{"issue":"Suppl 3","key":"b7","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3171\/jns.2000.93.supplement_3.0155","article-title":"Gamma Knife radiosurgery for trigeminal neuralgia: dose-volume histograms of the brainstem and trigeminal nerve","volume":"93","author":"Brisman R","year":"2000","unstructured":"Brisman R, Mooij R: Gamma Knife radiosurgery for trigeminal neuralgia: dose-volume histograms of the brainstem and trigeminal nerve. J Neurosurg 93 (Suppl 3):155\u2013158, 200010.3171\/jns.2000.93.supplement_3.015511143235"},{"key":"b8","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijrobp.2010.04.070","article-title":"Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer","volume":"78","author":"Brown JM","year":"2010","unstructured":"Brown JM, Diehn M, Loo BW Jr: Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer. Int J Radiat Oncol Biol Phys 78:323\u2013327, 20102083266310.1016\/j.ijrobp.2010.04.070"},{"key":"b9","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/STROKEAHA.115.011400","article-title":"Radiosurgery for cerebral arteriovenous malformations in A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA)-eligible patients: a multicenter study","volume":"47","author":"Ding D","year":"2016","unstructured":"Ding D, Starke RM, Kano H, Mathieu D, Huang P, Kondziolka D, : Radiosurgery for cerebral arteriovenous malformations in A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA)-eligible patients: a multicenter study. Stroke 47:342\u2013349, 201610.1161\/STROKEAHA.115.011400"},{"key":"b10","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijrobp.2005.09.028","article-title":"Conformity index: a review","volume":"64","author":"Feuvret L","year":"2006","unstructured":"Feuvret L, No\u00ebl G, Mazeron JJ, Bey P: Conformity index: a review. Int J Radiat Oncol Biol Phys 64:333\u2013342, 20061641436910.1016\/j.ijrobp.2005.09.028"},{"key":"b11","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0360-3016(99)00513-1","article-title":"Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients","volume":"46","author":"Flickinger JC","year":"2000","unstructured":"Flickinger JC, Kondziolka D, Lunsford LD, Kassam A, Phuong LK, Liscak R, : Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Int J Radiat Oncol Biol Phys 46:1143\u20131148, 200010.1016\/S0360-3016(99)00513-110725624"},{"key":"b12","series-title":"Neurosurg Clin N Am","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1042-3680(18)30682-X","article-title":"Dose prescription and dose-volume effects in radiosurgery","volume":"3","author":"Flickinger JC","year":"1992","unstructured":"Flickinger JC, Lunsford LD, Kondziolka D: Dose prescription and dose-volume effects in radiosurgery. Neurosurg Clin N Am 3:51\u201359, 1992163345210.1016\/S1042-3680(18)30682-X"},{"key":"b13","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.wneu.2013.01.127","article-title":"Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report","volume":"82","author":"Grant RA","year":"2014","unstructured":"Grant RA, Whicker M, Lleva R, Knisely JPS, Inzucchi SE, Chiang VL: Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report. World Neurosurg 82:195\u2013201, 20142338544810.1016\/j.wneu.2013.01.127"},{"key":"b14","series-title":"Radiother Oncol","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.radonc.2013.09.005","article-title":"Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer","volume":"109","author":"Guckenberger M","year":"2013","unstructured":"Guckenberger M, Klement RJ, Allg\u00e4uer M, Appold S, Dieckmann K, Ernst I, : Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. Radiother Oncol 109:13\u201320, 20132418306610.1016\/j.radonc.2013.09.005"},{"key":"b15","series-title":"ICRU Report 91, Prescribing, Recording, and Reporting of Stereotactic Treatments with Small Photon Beams","year":"2018","unstructured":"International Commission on Radiation Units & Measurements: ICRU Report 91, Prescribing, Recording, and Reporting of Stereotactic Treatments with Small Photon Beams. Bethesda, MD: ICRU, 2018"},{"issue":"16","key":"b16","series-title":"BMC Cancer","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-3-16","article-title":"Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis","volume":"3","author":"Jani AB","year":"2003","unstructured":"Jani AB, Hand CM, Pelizzari CA, Roeske JC, Krauz L, Vijayakumar S: Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis. BMC Cancer 3:16, 20031274472510.1186\/1471-2407-3-16"},{"key":"b17","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ijrobp.2005.07.980","article-title":"12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors","volume":"64","author":"Korytko T","year":"2006","unstructured":"Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, : 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 64:419\u2013424, 20061622684810.1016\/j.ijrobp.2005.07.980"},{"key":"b18","series-title":"Cancer Treat Rev","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ctrv.2013.05.002","article-title":"Stereotactic radiosurgery in the treatment of brain metastases: the current evidence","volume":"40","author":"Lippitz B","year":"2014","unstructured":"Lippitz B, Lindquist C, Paddick I, Peterson D, O\u2019Neill K, Beaney R: Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat Rev 40:48\u201359, 20142381028810.1016\/j.ctrv.2013.05.002"},{"issue":"3 Suppl","key":"b19","series-title":"Int J Radiat Oncol Biol Phys","first-page":"S28","article-title":"Radiation dose-volume effects of optic nerves and chiasm","volume":"76","author":"Mayo C","year":"2010","unstructured":"Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J: Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 76 (3 Suppl):S28\u2013S35, 2010"},{"key":"b20","series-title":"Radiat Oncol","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1748-717X-6-48","article-title":"Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis","volume":"6","author":"Minniti G","year":"2011","unstructured":"Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, : Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48, 20112157516310.1186\/1748-717X-6-48"},{"key":"b21","series-title":"J Radiat Res (Tokyo)","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1269\/jrr.11005","article-title":"Dose gradient analyses in Linac-based intracranial stereotactic radiosurgery using Paddick\u2019s gradient index: consideration of the optimal method for plan evaluation","volume":"52","author":"Ohtakara K","year":"2011","unstructured":"Ohtakara K, Hayashi S, Hoshi H: Dose gradient analyses in Linac-based intracranial stereotactic radiosurgery using Paddick\u2019s gradient index: consideration of the optimal method for plan evaluation. J Radiat Res (Tokyo) 52:592\u2013599, 201110.1269\/jrr.11005"},{"key":"b22","series-title":"Br J Radiol","first-page":"e640","article-title":"Consideration of optimal isodose surface selection for target coverage in micro-multileaf collimator-based stereotactic radiotherapy for large cystic brain metastases: comparison of 90%, 80% and 70% isodose surface-based planning","volume":"85","author":"Ohtakara K","year":"2012","unstructured":"Ohtakara K, Hayashi S, Tanaka H, Hoshi H: Consideration of optimal isodose surface selection for target coverage in micro-multileaf collimator-based stereotactic radiotherapy for large cystic brain metastases: comparison of 90%, 80% and 70% isodose surface-based planning. Br J Radiol 85:e640\u2013e646, 2012"},{"issue":"Suppl 3","key":"b23","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3171\/jns.2000.93.supplement_3.0219","article-title":"A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note","volume":"93","author":"Paddick I","year":"2000","unstructured":"Paddick I: A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J Neurosurg 93 (Suppl 3):219\u2013222, 20001114325210.3171\/jns.2000.93.supplement_3.0219"},{"issue":"Suppl","key":"b24","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3171\/sup.2006.105.7.194","article-title":"A simple dose gradient measurement tool to complement the conformity index","volume":"105","author":"Paddick I","year":"2006","unstructured":"Paddick I, Lippitz B: A simple dose gradient measurement tool to complement the conformity index. J Neurosurg 105 Suppl:194\u2013201, 20061850335610.3171\/sup.2006.105.7.194"},{"key":"b25","series-title":"Br J Radiol","doi-asserted-by":"publisher","first-page":"20140342","DOI":"10.1259\/bjr.20140342","article-title":"New conformity indices based on the calculation of distances between the target volume and the volume of reference isodose","volume":"87","author":"Park JM","year":"2014","unstructured":"Park JM, Park SY, Ye SJ, Kim JH, Carlson J, Wu HG: New conformity indices based on the calculation of distances between the target volume and the volume of reference isodose. Br J Radiol 87:20140342, 201410.1259\/bjr.2014034225225915"},{"key":"b26","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3171\/2010.5.JNS091635","article-title":"Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes","volume":"114","author":"Sheehan JP","year":"2011","unstructured":"Sheehan JP, Pouratian N, Steiner L, Laws ER, Vance ML: Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg 114:303\u2013309, 20112054059610.3171\/2010.5.JNS091635"},{"key":"b27","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3171\/2014.10.JNS141610","article-title":"Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors","volume":"123","author":"Sneed PK","year":"2015","unstructured":"Sneed PK, Mendez J, Vemer-van den Hoek JGM, Seymour ZA, Ma L, Molinaro AM, : Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg 123:373\u2013386, 20152597871010.3171\/2014.10.JNS141610"},{"key":"b28","series-title":"PLoS One","doi-asserted-by":"publisher","first-page":"e0196664","DOI":"10.1371\/journal.pone.0196664","article-title":"Dose gradient curve: a new tool for evaluating dose gradient","volume":"13","author":"Sung K","year":"2018","unstructured":"Sung K, Choi YE: Dose gradient curve: a new tool for evaluating dose gradient. PLoS One 13:e0196664, 201810.1371\/journal.pone.019666429698471"},{"key":"b29","series-title":"Br J Radiol","first-page":"e1058","article-title":"Dynamic conformal arc cranial stereotactic radiosurgery: implications of multileaf collimator margin on dose-volume metrics","volume":"85","author":"Tanyi JA","year":"2012","unstructured":"Tanyi JA, Doss EJ, Kato CM, Monaco DL, Meng LZ, Chen Y, : Dynamic conformal arc cranial stereotactic radiosurgery: implications of multileaf collimator margin on dose-volume metrics. Br J Radiol 85:e1058\u2013e1066, 2012"},{"key":"b30","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1227\/NEU.0000000000000448","article-title":"Comparison of plan quality and delivery time between volumetric arc therapy (RapidArc) and Gamma Knife radiosurgery for multiple cranial metastases","volume":"75","author":"Thomas EM","year":"2014","unstructured":"Thomas EM, Popple RA, Wu X, Clark GM, Markert JM, Guthrie BL, : Comparison of plan quality and delivery time between volumetric arc therapy (RapidArc) and Gamma Knife radiosurgery for multiple cranial metastases. Neurosurgery 75:409\u2013418, 201410.1227\/NEU.000000000000044824871143"},{"key":"b31","series-title":"Radiother Oncol","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0167-8140(01)00281-X","article-title":"Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors","volume":"59","author":"Wachter S","year":"2001","unstructured":"Wachter S, Gerstner N, Goldner G, P\u00f6tzi R, Wambersie A, P\u00f6tter R: Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors. Radiother Oncol 59:65\u201370, 200110.1016\/S0167-8140(01)00281-X11295208"},{"key":"b32","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S0360-3016(03)01563-3","article-title":"A simple and reliable index for scoring rival stereotactic radiosurgery plans","volume":"57","author":"Wagner TH","year":"2003","unstructured":"Wagner TH, Bova FJ, Friedman WA, Buatti JM, Bouchet LG, Meeks SL: A simple and reliable index for scoring rival stereotactic radiosurgery plans. Int J Radiat Oncol Biol Phys 57:1141\u20131149, 200310.1016\/S0360-3016(03)01563-314575847"},{"key":"b33","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0360-3016(99)00014-0","article-title":"Practical considerations in using calculated healthy-tissue complication probabilities for treatment-plan optimization","volume":"44","author":"Zaider M","year":"1999","unstructured":"Zaider M, Amols HII: Practical considerations in using calculated healthy-tissue complication probabilities for treatment-plan optimization. Int J Radiat Oncol Biol Phys 44:439\u2013447, 199910.1016\/S0360-3016(99)00014-010760441"},{"key":"b34","series-title":"J Radiosurg SBRT","first-page":"139","article-title":"Prescription to 50\u201375% isodose line may be optimum for linear accelerator based radiosurgery of cranial lesions","volume":"3","author":"Zhao B","year":"2014","unstructured":"Zhao B, Jin JY, Wen N, Huang Y, Siddiqui MS, Chetty IJ, : Prescription to 50\u201375% isodose line may be optimum for linear accelerator based radiosurgery of cranial lesions. J Radiosurg SBRT 3:139\u2013147, 201429296395"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/129\/Suppl1\/article-p118.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/129\/Suppl1\/article-p118.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/129\/Suppl1\/article-p118.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T21:54:28Z","timestamp":1743371668000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/129\/Suppl1\/article-p118.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":34,"journal-issue":{"issue":"Suppl1"},"URL":"https:\/\/doi.org\/10.3171\/2018.7.gks18694","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}